Reactive Gliosis in Neonatal Disorders: Friend or Foe for Neuroregeneration?

J Gargas, J Janowska, P Gebala, W Maksymiuk… - Cells, 2024 - mdpi.com
A developing nervous system is particularly vulnerable to the influence of
pathophysiological clues and injuries in the perinatal period. Astrocytes are among the first …

Deciphering the impact of cerebrospinal fluid on stem cell fate as a new mechanism to enhance clinical therapy development

K Radoszkiewicz, A Bzinkowska… - Frontiers in …, 2024 - frontiersin.org
Neural stem cells (NSCs) hold a very significant promise as candidates for cell therapy due
to their robust neuroprotective and regenerative properties. Preclinical studies using NSCs …

Management of Retinitis Pigmentosa Via Wharton's Jelly-Derived Mesenchymal Stem Cells or Combination With Magnovision: 3-Year Prospective Results

E Ozmert, U Arslan - Stem Cells Translational Medicine, 2023 - academic.oup.com
To investigate whether the natural progression rate of retinitis pigmentosa (RP) can be
decreased with subtenon Wharton's jelly-derived mesenchymal stem cell (WJ-MSC) …

[PDF][PDF] Stemness properties of SSEA-4+ subpopulation isolated from heterogenous Wharton's jelly mesenchymal stem/stromal cells

A Smolinska, M Chodkowska, A Kominek… - Frontiers in Cell and …, 2024 - researchgate.net
Background: High heterogeneity of mesenchymal stem/stromal cells (MSCs) due to different
degrees of differentiation of cell subpopulations poses a considerable challenge in …

Extracellular vesicles derived from hypoxia-preconditioned bone marrow mesenchymal stem cells ameliorate lower limb ischemia by delivering miR-34c

X Peng, J Liu, L Ren, B Liang, H Wang, J Hou… - Molecular and Cellular …, 2023 - Springer
Hypoxic mesenchymal stem cell-derived extracellular vesicles (EVs) have been suggested
as a promising therapy for various diseases. This study aims to determine the effect of EVs …